Figure 7.

Kaplan–Meier curve of 345 microarRAy-prognoSTics-in-breast-cancER (RASTER) study patients for 5-year distant recurrence-free interval (DRFI) assessed using BluePrint FF (A) and FFPE (B) tissues. Kaplan–Meier curves plotted for DRFI show comparable clinical performance of BluePrint Luminal-type (blue lines), HER2-type (green lines) and Basal-type (red lines) patients in matched FF and FFPE in a series of 345 early-stage breast cancer patients. P-values of significance are assessed using log-rank test and showed on the graphs. FF = Fresh Frozen, FFPE = formalin-fixed paraffin embedded.